Polycystic Ovary Syndrome (PCOS)
January 30th, 2026 by Sanvi Pandejee
Polycystic Ovary Syndrome, also known as PCOS, is a highly prevalent but frequently underrecognized endocrine disorder affecting a significant portion of women of reproductive age, with estimates ranging from about 9% to 18% in different populations. Despite this, many women experience delayed diagnosis, often seeing multiple healthcare providers over several years before being properly assessed; in one large international study, over one-third of women reported waiting more than two years and seeing several clinicians before receiving a PCOS diagnosis, with many dissatisfied with the information and care they received, according to PubMed. This diagnostic delay can leave women without appropriate metabolic screening or education about long-term risks, such as insulin resistance, type 2 diabetes, and cardiovascular disease, which are well documented features of PCOS and important to manage proactively.
When PCOS is not adequately diagnosed or managed, patients may face real health consequences. In addition, meta-analyses and large observational studies have shown that women with PCOS have a significantly increased risk of endometrial cancer, with some analyses reporting a roughly three- to four-fold higher risk compared to women without PCOS, likely due to chronic anovulation and prolonged estrogen exposure. Additional research also links PCOS with adverse pregnancy outcomes such as an elevated risk of gestational diabetes and preeclampsia. When clinicians dismiss symptoms, delay diagnosis, or fail to provide comprehensive care and counseling about these risks and management strategies, these shortcomings can reflect systemic gaps in women’s health care and, in certain cases, may rise to the level of medical malpractice if the standard of care is not met.
Links Used:
- https://pubmed.ncbi.nlm.nih.gov/27906550/
- https://www.ncbi.nlm.nih.gov/books/NBK459251/
- https://pubmed.ncbi.nlm.nih.gov/40740582/
Posted in: Health